Cellebrite DI (NASDAQ:CLBT – Free Report) had its price target hoisted by JPMorgan Chase & Co. from $12.00 to $14.00 in a research report sent to investors on Friday, Benzinga reports. The firm currently has an overweight rating on the stock. Several other analysts have also commented on CLBT. Needham & Company LLC raised their […]
Crescent Park Management L.P. grew its stake in Cellebrite DI Ltd. (NASDAQ:CLBT – Free Report) by 9.1% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 326,578 shares of the company’s stock after buying an additional 27,329 shares during the […]
Cellebrite DI (NASDAQ:CLBT – Get Free Report) posted its quarterly earnings data on Thursday. The company reported $0.08 EPS for the quarter, topping analysts’ consensus estimates of $0.06 by $0.02, Briefing.com reports. Cellebrite DI had a positive return on equity of 220.14% and a negative net margin of 32.57%. The company had revenue of $89.60 […]
Cellebrite DI (NASDAQ:CLBT) Given New $14.00 Price Target at Needham & Company LLC modernreaders.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from modernreaders.com Daily Mail and Mail on Sunday newspapers.
Cellebrite DI Ltd. (NASDAQ:CLBTW – Get Free Report) saw a large growth in short interest in the month of April. As of April 15th, there was short interest totalling 6,500 shares, a growth of 16.1% from the March 31st total of 5,600 shares. Based on an average daily trading volume, of 64,200 shares, the short-interest […]